首页 | 本学科首页   官方微博 | 高级检索  
     

金龙胶囊对结肠癌血管生成拟态及Mig-7的影响
引用本文:刘娇萍,袁昌劲,余涛,刘礼. 金龙胶囊对结肠癌血管生成拟态及Mig-7的影响[J]. 肿瘤防治研究, 2016, 43(12): 1059-1062. DOI: 10.3971/j.issn.1000-8578.2016.12.010
作者姓名:刘娇萍  袁昌劲  余涛  刘礼
作者单位:430014 武汉,华中科技大学同济医学院附属武汉中心医院中西医结合肿瘤科
基金项目:武汉市卫生计生委项目(WZ14Z17)
摘    要:目的 探讨金龙胶囊对结肠癌血管生成拟态(vasculogenic mimicry, VM)及迁移诱导蛋白7(Mig-7)的影响。方法 采用细胞三维培养技术观察HCT116、HT29结肠癌细胞株VM的形成能力。对VM(+)组细胞进行后续实验,实验分为空白组、中药组(金龙胶囊)和阳性对照组(200 μmol/L,5-氟尿嘧啶组),其中金龙胶囊组按培养液浓度分为低浓度(0.01 mg/ml)、中浓度(0.02 mg/ml)和高浓度组(0.04 mg/ml)三组。采用RT-PCR和Western blot法分别检测各组Mig-7 mRNA和Mig-7蛋白的表达。结果 HCT116细胞可形成VM,HT29细胞无形成VM能力;Mig-7在HCT116细胞中阳性表达;金龙胶囊高、中、低剂量及5-氟尿嘧啶组均可干扰HCT116细胞VM形成,下调Mig-7 mRNA和蛋白的表达,各药物组VM及Mig-7的表达量均低于空白对照组,差异有统计学意义(P<0.05),随着金龙胶囊剂量增大,VM及Mig-7的表达量逐渐减少。以金龙胶囊高剂量组(0.04 mg/ml)和5-氟尿嘧啶组效果更为明显(P<0.01),且5-氟尿嘧啶组效果优于金龙胶囊高剂量组(0.04 mg/ml)(P<0.05)。结论 VM(+)组细胞可表达Mig-7 mRNA和Mig-7蛋白,金龙胶囊抑制VM的形成,可能与下调Mig-7mRNA和Mig-7蛋白的表达有关。

关 键 词:金龙胶囊  结肠癌  血管生成拟态  迁移诱导蛋白7  
收稿时间:2016-06-24

Effect of Jinlong Capsule on Vasculogenic Mimicry and Mig-7 of Colon Cancer
LIU Jiaoping,YUAN Changjing,YU Tao,LIU Li. Effect of Jinlong Capsule on Vasculogenic Mimicry and Mig-7 of Colon Cancer[J]. Cancer Research on Prevention and Treatment, 2016, 43(12): 1059-1062. DOI: 10.3971/j.issn.1000-8578.2016.12.010
Authors:LIU Jiaoping  YUAN Changjing  YU Tao  LIU Li
Affiliation:Department of Oncology, Integrated Traditional Chinese and Western Medicine, The Central Hospital of Wuhan Tongji Medical College Huangzhong University of Science and Technology, Wuhan 430014, China
Abstract:Objective To explore the effect of Jinlong capsule on vasculogenic mimicry and Mig-7 of colon cancer. Methods To observe the capacity of forming VM about HCT116 colon cancer cells and HT29 colon cancer cells when cultured in three dimensional condition. The VM (+) cells for subsequent experiments, which were divided into blank group, Chinese medicine group (Jinlong capsule) and positive control group (5-fluorouracil, 200μmol/L). The Jinlong capsule culture was divided into low dose group (0.01mg/ml), medium dose group (0.02mg/ml) and high dose group (0.04mg/ml). The expression of Mig-7 mRNA and protein were tested by RT-PCR and Western blot, respectively. Results HCT116 colon cancer cells could form visible VM structure and express Mig-7. The high, medium, and low dose Jinlong Capsule and 5-fluorouracil group could inhibit the capacity of forming VM about HCT116 colon cancer cells and reduce the expression of Mig-7 mRNA and protein. The expression of VM and Mig-7 of each treated group were lower than that in the blank control group, the difference was statistically significant(P<0.05). The VM and Mig-7 expression gradually reduced with the increase of Jinlong capsule dose. The effect of Jinlong capsule high dose group (0.04 mg/ml) and 5-fluorouracil group were superior to others(P<0.01), and 5-fluorouracil group was better than Jinlong capsule high-dose group (0.04mg/ml) (P<0.05). Conclusion The VM(+) colon cancer cells could express Mig-7 mRNA and protein. Jinlong capsule can inhibit the formation of VM probably by reducing the expression of Mig-7 mRNA and protein.
Keywords:Jinlong Capsule  Colon cancer  Vasculogenic mimicry  Mig-7  R735.3+5
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号